1AI 0.00% 0.8¢ algorae pharmaceuticals limited

Ann: LCT files pericyte protective agent provisional patent, page-30

  1. 16,906 Posts.
    lightbulb Created with Sketch. 2404
    Not a dumb question. I would say it has a binary element in terms of "failure" i.e. there is no significant difference in outcome between the treated patients and the placebo controls. However there are varying grades of "success", from all the treated patents showing significant improvement in symptoms (maybe the equivalent of 5 years of disease progression) to only the last cohort showing halting of progression. But there are a lot of combinations in between.
    Last edited by whytee: 09/11/17
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $13.49M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $0 5

Buyers (Bids)

No. Vol. Price($)
3 279721 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1209087 10
View Market Depth
Last trade - 15.33pm 29/08/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.